Wnt-targeted hair loss treatment
Scope
Date
~
-
Bio & Pharma
Hanmi's Rolvedon set to post $10 mn in Q4 net sales in US
South Korean drugmaker Hanmi Pharmaceutical Co.’s neutropenia agent, Rolvedon (eflapegrastim-xnst), is forecast to achieve about $10 million i...
Feb 02, 2023 (Gmt+09:00)
-
Shipping & Shipbuilding
Samsung Heavy wins $495 million order for two LNG ships
Samsung Heavy Industries Co., a leading South Korean shipbuilder, said on Wednesday it has won a 609.7 billion won ($495 million) deal to build two ...
Feb 01, 2023 (Gmt+09:00)
-
Earnings
SK Hynix to halve investment after posting first quarterly loss in decade
SK Hynix Inc., the world’s second-largest memory chipmaker, said on Wednesday it will significantly slash its investment for this year after p...
Feb 01, 2023 (Gmt+09:00)
-
Electric vehicles
LG Elec eyes profit from EV powertrain, car lighting biz
LG Electronics Inc., the world’s leading home appliance maker, aims to take profit from the electric vehicle powertrain and car lighting units...
Jan 31, 2023 (Gmt+09:00)
-
Earnings
Hyundai Mobis bags record $4.6 bn orders from global carmakers
South Korea's Hyundai Mobis, a key affiliate of Hyundai Motor Group, last year enjoyed its best year in orders received from abroad.The company on T...
Jan 31, 2023 (Gmt+09:00)
-
Pension funds
NPS underperforms global peers by returns for Q1-Q3 2022
South Korea's National Pension Service (NPS), the world's third-largest pension fund, ranked 10th out of the global 42 state-owned investors by rate...
Jan 31, 2023 (Gmt+09:00)
-
Korean chipmakers
Samsung considers chip output cut as first-quarter loss looms large
Samsung Electronics Co., the world’s largest memory chipmaker, is considering slashing its semiconductor production as the company is heading ...
Jan 27, 2023 (Gmt+09:00)
-
Bio & Pharma
Bridge Biotherapeutics, Pinotbio develop lung cancer treatment
South Korea's biotech companies Bridge Biotherapeutics Inc. and Pinotbio on Thursday said they will jointly develop new antibody-drug conjugates (AD...
Jan 27, 2023 (Gmt+09:00)
-
Earnings
Hyundai vows $8.5 billion investment after record 2022 sales, profit
South Korea’s top automaker Hyundai Motor Co. said on Thursday it will spend 10.5 trillion won ($8.5 billion) this year to ramp up facilities ...
Jan 26, 2023 (Gmt+09:00)
-
Electronics
LG Elec targets indoor golf market with its ProBeam projector
LG Electronics Inc. is targeting the overseas indoor golf market with its premium commercial projector LG ProBeam.The company said on Thursday that ...
Jan 26, 2023 (Gmt+09:00)
-
Bio & Pharma
HK inno.N to introduce biosimilars for bone disease treatment from Spain
South Korea's biohealth company HK inno.N said on Wednesday that it has signed an agreement with Spanish pharmaceutical company mAbxience SA to intr...
Jan 26, 2023 (Gmt+09:00)
-
Bio & Pharma
Inventage Lab launches clinical trials for addiction treatment in Australia
South Korea's Inventage Lab, a developer of a drug delivery system platform, on Wednesday said it received approval from the Human Research Ethics C...
Jan 26, 2023 (Gmt+09:00)
-
Bio & Pharma
ST Pharm exports $14.6 mn worth of drug ingredients to Europe
ST Pharm Co., a South Korean company specializing in contract development and manufacturing of drug ingredients, has signed a supply contract worth ...
Jan 20, 2023 (Gmt+09:00)
-
Construction
Hyundai E&C wins record $28.4 billion in new orders last year
South Korean builder Hyundai Engineering & Construction last year earned sales of 21 trillion won ($17 billion) thanks to growth in the domestic...
Jan 20, 2023 (Gmt+09:00)
-
Bio & Pharma
LG Chem completes acquisition of US biotech firm AVEO
LG Chem Ltd. is set to complete its $571 million purchase of the US biotech firm AVEO Pharmaceuticals Inc. on Friday, which would strengthen its ant...
Jan 19, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma's Sanfilippo treatment eligible for FDA priority review
GC Biopharma Corp. said on Wednesday that its Sanfilippo type A treatment, which is under joint development with Novel Pharma, a bio-venture special...
Jan 18, 2023 (Gmt+09:00)
-
Bio & Pharma
MedPacto's anti-cancer substance designated as US FDA fast-track item
South Korean biotech company MedPacto Inc. ’s Vactosertib monotherapy for osteosarcoma patients has been designated as a fast-track developmen...
Jan 18, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for EMA approval of smaller dose formulation of Yuflyma
Celltrion Inc. announced on Monday it applied to the European Medicines Agency (EMA) for approval of a 20 mg/0.2 mL formulation of Yuflyma, a biosim...
Jan 16, 2023 (Gmt+09:00)
-
ECM/DCM
S.Korean brokerage lowers stock forecast for S-Oil over poor prospects
South Korea's Eugene Investment & Securities on Monday cut S-Oil Corp.'s target share price from 140,000 won ($113.5) to 133,000 won due to a lo...
Jan 16, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Chemicals launches uremia itching treatment tablet
SK Chemicals said on Monday that it has launched Remitch in orally disintegrating tablets, a treatment for intractable uremic pruritus (uremia itchi...
Jan 16, 2023 (Gmt+09:00)
-
Bio & Pharma
HK inno.N gets approval to sell K-CAB in Singapore
South Korean biohealth company HK inno.N said on Wednesday that it has received an item approval for K-CAB, a new drug for gastroesophageal reflux d...
Jan 12, 2023 (Gmt+09:00)
-
Bio & Pharma
Prestige Biopharma attains patent for solid cancer treatment antibody
Prestige Biopharma Korea said on Tuesday that it has obtained a domestic patent for the CTHRC1 neutralizing antibody of the drug candidate PBP1710. ...
Jan 12, 2023 (Gmt+09:00)
-
Beauty & Cosmetics
Korean cosmetics shares rise as China reopens borders
Shares in South Korean cosmetics brands are gaining momentum after brokerage houses lifted their target prices on expectations that China’s bo...
Jan 11, 2023 (Gmt+09:00)
-
Alternative investments
S.Korea's DLS incurring losses due to stock slump exceed $800 billion
South Korea's derivatives-linked securities that entered the knock-in or loss period due to stock slumps at home and abroad exceeded 1 trillion won ...
Jan 09, 2023 (Gmt+09:00)
-
Bio & Pharma
Kolon signs MOU with Hanyang Univ. to develop gene therapy treatments
Kolon Industries Inc.'s Future Technology Institute said on Thursday that it had signed a memorandum of understanding with the Hanyang University In...
Jan 05, 2023 (Gmt+09:00)
-
Batteries
EcoPro Group nearly doubles sales target to $7.8 billion this year
South Korea's EcoPro Group has set its sales target this year at 10 trillion won ($7.8 billion), nearly double that of last year, under a strategy t...
Jan 05, 2023 (Gmt+09:00)
-
Airlines
Korean LCCs cancel China-bound flights due to COVID-19
Toughened COVID-19 testing requirements on Chinese travelers will likely dent hopes for South Korea's low-cost airlines to recover from three years ...
Jan 04, 2023 (Gmt+09:00)
-
Bio & Pharma
NeoImmuneTech, US think tank to develop treatment for acute radiation syndrome
Biopharmaceutical company NeoImmuneTech has grabbed an opportunity to supply new drug candidates in development as strategic items to the US gover...
Jan 04, 2023 (Gmt+09:00)
-
Automobiles
Hyundai, Kia aim to outpace industry growth in 2023
The Hyundai Motor Group is aiming to boost sales by 10% this year from 2022, above an estimated single-digit growth in the global automotive market....
Jan 03, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion's Remsima receives approval in 100 countries in 10 years
South Korea's most valuable biopharmaceutical company Celltrion Inc. said on Tuesday that its antibody biosimilar Remsima (ingredient: infliximab) h...
Jan 03, 2023 (Gmt+09:00)
Latest News
- 1 Micron set to supply SOCAMM chips to Nvidia ahead of Samsung, SK Hynix
- 2 POSCO Future M breaks with China in cathode supply chain
- 3 GIC resumes Seoul Finance Center sale in potential megadeal
- 4 South Korea’s Lee, China’s Xi agree on closer ties, peace on Korean Peninsula
- 5 Invesco, SK D&D likely to buy co-living building in Seoul